{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:34:55Z","timestamp":1773221695223,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T00:00:00Z","timestamp":1403740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T00:00:00Z","timestamp":1403740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2014.265","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T13:13:24Z","timestamp":1403788404000},"page":"e1305-e1305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Validation of a chloroquine-induced cell death mechanism for clinical use against malaria"],"prefix":"10.1038","volume":"5","author":[{"given":"J-H","family":"Ch'ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-Q","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Y","family":"Gun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W-N","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z-W","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L-K","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K T","family":"Batty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Renia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K S-W","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,26]]},"reference":[{"key":"BFcddis2014265_CR1","doi-asserted-by":"crossref","unstructured":"The malERA Consultative Group on Drugs. A research agenda for malaria eradication: drugs. PLoS Med 2011; 8: e1000402.","DOI":"10.1371\/journal.pmed.1000402"},{"key":"BFcddis2014265_CR2","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1021\/jm100410f","volume":"53","author":"BK Yeung","year":"2010","unstructured":"Yeung BK, Zou B, Rottmann M, Lakshminarayana SB, Ang SH, Leong SY et al. Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria. J Med Chem 2010; 53: 5155\u20135164.","journal-title":"J Med Chem"},{"key":"BFcddis2014265_CR3","first-page":"1","volume":"17","author":"JN Burrows","year":"2013","unstructured":"Burrows JN, Burlot E, Campo B, Cherbuin S, Jeanneret S, Leroy D et al. Antimalarial drug discovery\u2014the path towards eradication. Parasitology 2013; 17: 1\u201312.","journal-title":"Parasitology"},{"key":"BFcddis2014265_CR4","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/srep01734","volume":"3","author":"JH Ch'ng","year":"2013","unstructured":"Ch'ng JH, Mok S, Bozdech Z, Lear MJ, Boudhar A, Russell B et al. A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria. Sci Rep 2013; 3: 1734.","journal-title":"Sci Rep"},{"key":"BFcddis2014265_CR5","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1038\/cddis.2010.2","volume":"1","author":"JH Ch'ng","year":"2010","unstructured":"Ch'ng JH, Kotturi SR, Chong AG, Lear MJ, Tan KS . A programmed cell death pathway in the malaria parasite Plasmodium falciparum has general features of mammalian apoptosis but is mediated by clan CA cysteine proteases. Cell Death Dis 2010; 1: e26.","journal-title":"Cell Death Dis"},{"key":"BFcddis2014265_CR6","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1038\/cddis.2011.97","volume":"2","author":"JH Ch\u2019ng","year":"2011","unstructured":"Ch\u2019ng JH, Liew K, Goh AS, Sidhartha E, Tan KS . Drug-induced permeabilization of parasite\u2019s digestive vacuole is a key trigger of programmed cell death in Plasmodium falciparum. Cell Death Dis 2011; 2: e216.","journal-title":"Cell Death Dis"},{"key":"BFcddis2014265_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.pt.2012.02.005","volume":"28","author":"JH Ch'ng","year":"2012","unstructured":"Ch'ng JH, Renia L, Nosten F, Tan KS . Can we teach an old drug new tricks? Trends Parasitol 2012; 28: 220\u2013224.","journal-title":"Trends Parasitol"},{"key":"BFcddis2014265_CR8","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.152.3727.1374","volume":"152","author":"PB Macomber","year":"1966","unstructured":"Macomber PB, O'Brien RL, Hahn FE . Chloroquine: physiological basis of drug resistance in Plasmodium berghei. Science 1966; 152: 1374\u20131375.","journal-title":"Science"},{"key":"BFcddis2014265_CR9","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/0006-2952(87)90080-3","volume":"36","author":"Y Zhang","year":"1987","unstructured":"Zhang Y, Hempelmann E . Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins. Biochem Pharmacol 1987; 36: 1267\u20131273.","journal-title":"Biochem Pharmacol"},{"key":"BFcddis2014265_CR10","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1073\/pnas.022630099","volume":"99","author":"R Banerjee","year":"2002","unstructured":"Banerjee R, Liu J, Beatty W, Pelosof L, Klemba M, Goldberg DE . Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci USA 2002; 99: 990\u2013995.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014265_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/978-1-4419-8414-2_3","volume":"712","author":"PJ Rosenthal","year":"2011","unstructured":"Rosenthal PJ . Falcipains and other cysteine proteases of malaria parasites. Adv Exp Med Biol 2011; 712: 30\u201348.","journal-title":"Adv Exp Med Biol"},{"key":"BFcddis2014265_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2165\/00003088-199631040-00003","volume":"31","author":"J Ducharme","year":"1996","unstructured":"Ducharme J, Farinotti R . Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clin Pharmacokinet 1996; 31: 257\u2013274.","journal-title":"Clin Pharmacokinet"},{"key":"BFcddis2014265_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","volume":"79","author":"M Foley","year":"1998","unstructured":"Foley M, Tilley L . Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 1998; 79: 55\u201387.","journal-title":"Pharmacol Ther"},{"key":"BFcddis2014265_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1550-7408.1983.tb05336.x","volume":"30","author":"A Yayon","year":"1983","unstructured":"Yayon A, Vande Waa JA, Yayon M, Geary TG, Jensen JB . Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J Protozool 1983; 30: 642\u2013647.","journal-title":"J Protozool"},{"key":"BFcddis2014265_CR15","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/2131048a0","volume":"213","author":"DC Warhurst","year":"1967","unstructured":"Warhurst DC, Killick-Kendrick R . Spontaneous resistance to chloroquine in a strain of rodent malaria (Plasmodium berghei yoelii). Nature 1967; 213: 1048\u20131049.","journal-title":"Nature"},{"key":"BFcddis2014265_CR16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/214935a0","volume":"214","author":"DC Warhurst","year":"1967","unstructured":"Warhurst DC, Hockley DJ . Mode of action of chloroquine on Plasmodium berghei and P. cynomolgi. Nature 1967; 214: 935\u2013936.","journal-title":"Nature"},{"key":"BFcddis2014265_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/214937a0","volume":"214","author":"PB Macomber","year":"1967","unstructured":"Macomber PB, Sprinz H . Morphological effects of chloroquine on Plasmodium berghei in mice. Nature 1967; 214: 937\u2013939.","journal-title":"Nature"},{"key":"BFcddis2014265_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00007691-198506000-00013","volume":"7","author":"L Rombo","year":"1985","unstructured":"Rombo L, Ericsson O, Alvan G, Lindstrom B, Gustafsson LL, Sjoqvist F . Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit 1985; 7: 211\u2013215.","journal-title":"Ther Drug Monit"},{"key":"BFcddis2014265_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00003088-199630040-00002","volume":"30","author":"S Krishna","year":"1996","unstructured":"Krishna S, White NJ . Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet 1996; 30: 263\u2013299.","journal-title":"Clin Pharmacokinet"},{"key":"BFcddis2014265_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1051\/parasite\/1994013219","volume":"1","author":"G Cambie","year":"1994","unstructured":"Cambie G, Verdier F, Gaudebout C, Clavier F, Ginsburg H . The pharmacokinetics of chloroquine in healthy and Plasmodium chabaudi-infected mice: implications for chronotherapy. Parasite 1994; 1: 219\u2013226.","journal-title":"Parasite"},{"key":"BFcddis2014265_CR21","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1128\/AAC.00067-11","volume":"55","author":"BR Moore","year":"2011","unstructured":"Moore BR, Page-Sharp M, Stoney JR, Ilett KF, Jago JD, KT. Batty . Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model. Antimicrob Agents Chemother 2011; 55: 3899\u20133907.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFcddis2014265_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJM198812083192301","volume":"319","author":"NJ White","year":"1988","unstructured":"White NJ, Miller KD, Churchill FC, Berry C, Brown J, Williams SB et al. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med 1988; 319: 1493\u20131500.","journal-title":"N Engl J Med"},{"key":"BFcddis2014265_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1128\/AAC.01111-08","volume":"53","author":"J Ursing","year":"2009","unstructured":"Ursing J, Kofoed PE, Rodrigues A, Bergqvist Y, Rombo L . Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau. Antimicrob Agents Chemother 2009; 53: 180\u2013185.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFcddis2014265_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/infdis\/jiq001","volume":"203","author":"J Ursing","year":"2011","unstructured":"Ursing J, Kofoed PE, Rodrigues A, Blessborn D, Thoft-Nielsen R, Bjorkman A et al. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial. J Infect Dis 2011; 203: 109\u2013116.","journal-title":"J Infect Dis"},{"key":"BFcddis2014265_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1128\/AAC.35.3.406","volume":"35","author":"E Pussard","year":"1991","unstructured":"Pussard E, Lepers JP, Clavier F, Raharimalala L, Le Bras J, Frisk-Holmberg M et al. Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother 1991; 35: 406\u2013409.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFcddis2014265_CR26","doi-asserted-by":"publisher","first-page":"205ra135","DOI":"10.1126\/scitranslmed.3006684","volume":"5","author":"RP Bakshi","year":"2013","unstructured":"Bakshi RP, Nenortas E, Tripathi AK, Sullivan DJ, Shapiro TA . Model system to define pharmacokinetic requirements for antimalarial drug efficacy. Sci Transl Med 2013; 5: 205ra135.","journal-title":"Sci Transl Med"},{"key":"BFcddis2014265_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/srep00118","volume":"1","author":"B Malleret","year":"2011","unstructured":"Malleret B, Claser C, Ong AS, Suwanarusk R, Sriprawat K, Howland SW et al. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci Rep 2011; 1: 118.","journal-title":"Sci Rep"},{"key":"BFcddis2014265_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1475-2875-10-96","volume":"10","author":"C Spadafora","year":"2011","unstructured":"Spadafora C, Gerena L, Kopydlowski KM . Comparison of the in vitro invasive capabilities of Plasmodium falciparum schizonts isolated by Percoll gradient or using magnetic based separation. Malar J 2011; 10: 96.","journal-title":"Malar J"},{"key":"BFcddis2014265_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/infdis\/jiq036","volume":"203","author":"A Ecker","year":"2011","unstructured":"Ecker A, Lakshmanan V, Sinnis P, Coppens I, Fidock DA . Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes. J Infect Dis 2011; 203: 228\u2013236.","journal-title":"J Infect Dis"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2014265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014265","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:13:06Z","timestamp":1672960386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2014265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,26]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"alternative-id":["BFcddis2014265"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.265","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,26]]},"assertion":[{"value":"17 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}